147 related articles for article (PubMed ID: 34161897)
1. Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma.
Lenze NR; Farquhar DR; Sheth S; Zevallos JP; Lumley C; Blumberg J; Patel S; Hackman T; Weissler MC; Yarbrough WG; Olshan AF; Zanation AM
Oral Oncol; 2021 Aug; 119():105377. PubMed ID: 34161897
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes.
Lenze NR; Farquhar D; Sheth S; Zevallos JP; Blumberg J; Lumley C; Patel S; Hackman T; Weissler MC; Yarbrough WG; Zanation AM; Olshan AF
Laryngoscope; 2021 Jun; 131(6):1301-1309. PubMed ID: 33170518
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic status, human papillomavirus, and overall survival in head and neck squamous cell carcinomas in Toronto, Canada.
Chu KP; Habbous S; Kuang Q; Boyd K; Mirshams M; Liu FF; Espin-Garcia O; Xu W; Goldstein D; Waldron J; O'Sullivan B; Huang SH; Liu G
Cancer Epidemiol; 2016 Feb; 40():102-12. PubMed ID: 26706365
[TBL] [Abstract][Full Text] [Related]
4. Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinoma.
Yan EZ; Wahle BM; Massa ST; Zolkind P; Paniello RC; Pipkorn P; Jackson RS; Rich JT; Puram SV; Mazul AL
Cancer Med; 2023 Apr; 12(8):9976-9987. PubMed ID: 36847063
[TBL] [Abstract][Full Text] [Related]
5. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
[TBL] [Abstract][Full Text] [Related]
6. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
7. Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.
Laban S; Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende CC; Dyckhoff G; Boscolo-Rizzo P; Ezić J; Marienfeld R; Möller P; Kraus JM; Völkel G; Kestler HA; Brunner C; Schuler PJ; Wigand MC; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Waterboer T; Butt J
Clin Cancer Res; 2019 Dec; 25(24):7405-7412. PubMed ID: 31444248
[TBL] [Abstract][Full Text] [Related]
8. Impact of Smoking on the Survival of Patients With High-risk HPV-positive HNSCC: A Meta-analysis.
Alotaibi M; Valova V; HÄnsel T; Stromberger C; Kofla G; Olze H; Piwonski I; Albers A; Ochsenreither S; Coordes A
In Vivo; 2021; 35(2):1017-1026. PubMed ID: 33622897
[TBL] [Abstract][Full Text] [Related]
9. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and clinicopathological correlation of human papillomavirus in head and neck squamous cell carcinoma in India: A systematic review article.
Nandi S; Mandal A; Chhebbi M
Cancer Treat Res Commun; 2021; 26():100301. PubMed ID: 33401132
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma.
Tang B; Zhu G; Chen C; Zheng S; Pu Y; Xu Y; Huang H; Wang G; Huang D; Liu Y; Zhang X
Laryngoscope; 2021 Aug; 131(8):1774-1781. PubMed ID: 33592124
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of HPV status among patients with hypopharyngeal carcinoma: a population-based study.
Abdel-Rahman O
Clin Transl Oncol; 2020 Sep; 22(9):1645-1650. PubMed ID: 31939101
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus and head and neck squamous cell carcinoma in a UK population: Is there an association?
Al-Dabbagh R; Al-Hazmi N; Alhazzazi TY; Barrett AW; Speight PM
Indian J Cancer; 2022; 59(1):65-72. PubMed ID: 33753602
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
15. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
17. HPV Positive Status Is a Favorable Prognostic Factor in Non-Nasopharyngeal Head and Neck Squamous Cell Carcinoma Patients: A Retrospective Study From the Surveillance, Epidemiology, and End Results Database.
Wu Q; Wang M; Liu Y; Wang X; Li Y; Hu X; Qiu Y; Liang W; Wei Y; Zhong Y
Front Oncol; 2021; 11():688615. PubMed ID: 34631523
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
19. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.
Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
